Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cancers|April 23, 2022
Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)Annika Kasprzak, Kathrin Nachtkamp, Norbert Gattermann, et al.
Deutsches Arzteblatt International|January 31, 2023
Myelodysplastic Syndromes: New Methods of Diagnosis, Prognostication, and TreatmentKathrin Nachtkamp, Guido Kobbe, Norbert Gattermann, et al.
Expert Review of Hematology|June 23, 2021
Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblastsFelicitas Schulz, Kathrin Nachtkamp, Annika Kasprzak, et al.
Frontiers in Oncology|April 26, 2024
Comparison of cytomorphology and histomorphology in myelodysplastic syndromesKathrin Nachtkamp, Corinna Strupp, Rosa Faoro, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?Annika Kasprzak, Jennifer Kaivers, Kathrin Nachtkamp, et al.
Haematologica|April 2, 2009
The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndromeEsther Zipperer, Daniela Pelz, Kathrin Nachtkamp, et al.
Leukemia Research|February 3, 2009
Impact on survival of different treatments for myelodysplastic syndromes (MDS)Kathrin Nachtkamp, Andrea Kündgen, Corinna Strupp, et al.
Leukemia Research|May 9, 2012
Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registryJudith Neukirchen, Frank Fox, Andrea Kündgen, et al.
International Journal of Laboratory Hematology|January 29, 2024
Validation of a novel algorithm with a high specificity in ruling out MDSFelicitas Schulz, Kathrin Nachtkamp, Howard S Oster, et al.
Annals of Hematology|June 10, 2026
Prognostic impact of bone marrow iron and serum ferritin in patients with myelodysplastic syndromesAnnika Kasprzak, Felicitas Schulz, Kathrin Nachtkamp, et al.
Pageof 5